This inventor holds 1 USPTO granted patent. Top assignees: The Asan Foundation, University of Ulsan Foundation for Industry Cooperation. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2023
Title: Yeon Mok Oh: Innovator in Skin Disease Treatment
Introduction
Yeon Mok Oh is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of dermatology through his innovative research and development of therapeutic compositions for skin diseases. His work focuses on utilizing advanced stem cell technology to improve treatment outcomes for patients.
Latest Patents
Yeon Mok Oh holds a patent for a composition aimed at improving, preventing, or treating skin diseases. The patent, titled "Composition for improving, preventing or treating skin diseases comprising induced pluripotent stem cell-derived mesenchymal stem cell and exosome derived therefrom," outlines a pharmaceutical composition that includes induced pluripotent stem cell-derived mesenchymal stem cells (iMSC) and exosomes as active ingredients. This invention offers a novel approach to enhance immunomodulating functions compared to conventional mesenchymal stem cells.
Career Highlights
Throughout his career, Yeon Mok Oh has been associated with notable organizations, including the Asan Foundation and the University of Ulsan Foundation for Industry Cooperation. His work in these institutions has allowed him to advance his research and collaborate with other experts in the field.
Collaborations
Yeon Mok Oh has worked alongside talented colleagues such as Jin Ho Yu and Sue Kim. Their collaborative efforts have contributed to the development of innovative solutions in the treatment of skin diseases.
Conclusion
Yeon Mok Oh's contributions to the field of dermatology through his innovative patent and collaborative work highlight his commitment to improving patient care. His research continues to pave the way for advancements in skin disease treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile